Tracer library / [90Y]Y-90-DTPA-rituximab

[90Y]Y-90-DTPA-rituximab

Also written as Y-90-DTPA-rituximab; Y-90-DTPA-Rituximab

Radionuclide: Y-90 t½ 3843.6 min
Modality: Therapy
Production route: —
Stage: —
Syntheses indexed: 0

Lymphoma

What it is

Compound class: DTPA-conjugated anti-CD20 monoclonal antibody (rituximab) immunoconjugate
Target / mechanism: CD20 PMID 27980563
Clinical application: Non-Hodgkin's lymphoma (NHL) radioimmunotherapy/imaging PMID 27980563
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [90Y]Y-90-DTPA-rituximab, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 27980563: 'p-SCN-Bn-DTPA [2-(4-isothiocyanatobenzyl)-diethylenetriaminepentaacetic acid]'.